ATI RN
Cardiovascular Treatment Drugs Questions
Question 1 of 5
Which statement about the treatment of clients with panic disorder is inaccurate?
Correct Answer: A
Rationale: Correct Answer: A Rationale: 1. Benzodiazepines are not recommended as long-term treatment for panic disorder due to their highly addictive nature and potential for tolerance. 2. The treatment of choice for panic disorder is typically SSRIs or cognitive-behavioral therapy. 3. Addiction potential is a significant concern with benzodiazepines, making them unsuitable for long-term use. 4. Clients with panic disorder may benefit from short-term use of benzodiazepines for acute anxiety episodes, but not as a long-term solution. 5. Other treatment options like therapy, SSRIs, and relaxation techniques are preferred for long-term management of panic disorder.
Question 2 of 5
The nurse knows that a patient’s total cholesterol level should be within which range?
Correct Answer: A
Rationale: Step-by-step rationale: 1. The optimal total cholesterol level is below 200 mg/dL for heart health. 2. Levels between 200-225 mg/dL are borderline high, increasing heart disease risk. 3. Levels between 225-250 mg/dL are high, indicating potential heart disease risk. 4. Levels greater than 250 mg/dL are very high, posing significant heart disease risk. Therefore, choice A (150 to 200 mg/dL) is correct for maintaining heart health. Other choices are incorrect as they indicate elevated or high cholesterol levels, increasing cardiovascular risk.
Question 3 of 5
An obese patient has schizophreni Medications that block which receptors would contribute to further weight gain?
Correct Answer: A
Rationale: The correct answer is A: H1 receptors. Blocking H1 receptors can lead to weight gain by increasing appetite and reducing energy expenditure. Histamine receptors play a role in regulating appetite and metabolism. Choices B, C, and D are incorrect. Blocking 5-HT2 receptors may cause weight loss, GABA receptors are not directly involved in weight regulation, and acetylcholine receptors do not significantly impact weight gain.
Question 4 of 5
A patient mentions, “My doctor told me I was going to have a PET scan that would make my brain light up. Does that mean I’m getting an electrical jolt?” The best reply would be:
Correct Answer: C
Rationale: The correct answer is C because it provides a clear and accurate explanation of what a PET scan actually does. It states that PET scans involve an injected substance that shows areas of high brain activity, not electrical activity. This response clarifies the misunderstanding and educates the patient on how PET scans work. Choice A is incorrect because it only compares PET scans to electroconvulsive therapy without addressing the patient's specific concern about electrical jolts. Choice B is incorrect as it only distinguishes between PET scans and electroconvulsive therapy without addressing the patient's misconception about brain activity and electrical jolts. Choice D is incorrect because it inaccurately describes PET scans as showing electrical activity in the form of light bands, which is not how PET scans work. It is essential to provide accurate information to address the patient's concerns effectively.
Question 5 of 5
A patient has been given succinylcholine (Anectine) after a severe injury that necessitated controlled ventilation. The physician now wants to reverse the paralysis. The nurse would expect to use which drug to reverse the succinylcholine?
Correct Answer: C
Rationale: The correct answer is C: neostigmine (Prostigmin). Neostigmine is a cholinesterase inhibitor that helps reverse the effects of succinylcholine by increasing acetylcholine levels at the neuromuscular junction. This leads to the competitive inhibition of succinylcholine, allowing the patient to regain muscle function. Valium (A) is a benzodiazepine used for anxiety and muscle relaxation, not for reversing paralysis. Caffeine (B) is a stimulant that does not reverse muscle paralysis. Vecuronium (D) is a non-depolarizing neuromuscular blocking agent and cannot reverse succinylcholine paralysis.